Macrogenics Inc (MGNX)
4.47
-0.21
(-4.49%)
USD |
NASDAQ |
Jun 14, 16:00
4.57
+0.10
(+2.24%)
After-Hours: 20:00
Macrogenics Market Cap: 279.97M for June 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 14, 2024 | 279.97M |
| June 13, 2024 | 293.12M |
| June 12, 2024 | 312.54M |
| June 11, 2024 | 308.78M |
| June 10, 2024 | 286.86M |
| June 07, 2024 | 283.73M |
| June 06, 2024 | 292.50M |
| June 05, 2024 | 307.53M |
| June 04, 2024 | 273.08M |
| June 03, 2024 | 280.60M |
| May 31, 2024 | 256.17M |
| May 30, 2024 | 265.57M |
| May 29, 2024 | 259.30M |
| May 28, 2024 | 271.83M |
| May 24, 2024 | 284.98M |
| May 23, 2024 | 289.99M |
| May 22, 2024 | 294.38M |
| May 21, 2024 | 266.82M |
| May 20, 2024 | 266.82M |
| May 17, 2024 | 273.40M |
| May 16, 2024 | 320.68M |
| May 15, 2024 | 295.00M |
| May 14, 2024 | 278.72M |
| May 13, 2024 | 274.33M |
| May 10, 2024 | 207.32M |
| Date | Value |
|---|---|
| May 09, 2024 | 918.83M |
| May 08, 2024 | 918.21M |
| May 07, 2024 | 1.005B |
| May 06, 2024 | 1.025B |
| May 03, 2024 | 981.47M |
| May 02, 2024 | 952.17M |
| May 01, 2024 | 972.82M |
| April 30, 2024 | 924.64M |
| April 29, 2024 | 927.15M |
| April 26, 2024 | 910.88M |
| April 25, 2024 | 898.99M |
| April 24, 2024 | 982.20M |
| April 23, 2024 | 1.015B |
| April 22, 2024 | 964.06M |
| April 19, 2024 | 976.57M |
| April 18, 2024 | 1.005B |
| April 17, 2024 | 1.007B |
| April 16, 2024 | 1.044B |
| April 15, 2024 | 1.060B |
| April 12, 2024 | 1.097B |
| April 11, 2024 | 1.158B |
| April 10, 2024 | 1.142B |
| April 09, 2024 | 1.132B |
| April 08, 2024 | 1.148B |
| April 05, 2024 | 1.141B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
138.00M
Minimum
Jun 16 2022
2.139B
Maximum
Apr 29 2021
786.43M
Average
596.72M
Median
Dec 29 2023
Market Cap Benchmarks
| Moderna Inc | 53.67B |
| Allurion Technologies Inc | 58.98M |
| Novavax Inc | 2.121B |
| Viking Therapeutics Inc | 5.736B |
| Verrica Pharmaceuticals Inc | 344.45M |
Market Cap Related Metrics
| PS Ratio | 6.652 |
| Price to Book Value | 2.637 |
| Price | 4.47 |
| Earnings Yield | -8.72% |